Unknown

Dataset Information

0

Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis.


ABSTRACT:

Background

Glomerular deposition of C4d is a widely used biomarker for activation of the lectin pathway in the complement system and is reported to be associated with kidney progression in immunoglobulin A nephropathy (IgAN). The aim of this study was to evaluate whether glomerular C4d deposition, as a new biomarker, improves the prediction of kidney prognosis in IgAN.

Study design

Systematic review and meta-analysis.

Setting & population

Patients with biopsy-proven primary IgAN without age limitations.Selection Criteria for Studies: Cross-sectional or cohort studies reporting the prevalence of glomerular C4d deposition or evaluating its association with IgAN progression.

Predictor

Glomerular C4d deposition.

Outcome

Composite progression event of a >30% decline in estimated glomerular filtration rate or end-stage kidney disease.

Results

12 studies with 1,251 patients were included. The prevalence of glomerular C4d deposition was 34% (95% CI, 27%-41%), with large heterogeneity (I 2 = 86%; P < 0.001). Patients with C4d deposition had lower estimated glomerular filtration rates (mean difference [MD], -11.48; 95% CI, -18.27 to -4.70; P < 0.001) as well as higher urinary protein-creatinine ratios (MD, 0.87; 95% CI, 0.53-1.21; P < 0.001) or 24-hour urinary protein excretion (MD, 0.99; 95% CI, 0.50-1.47; P < 0.001) and higher risk for hypertension (relative risk [RR], 1.45; 95% CI, 1.06-1.99; P = 0.02) than patients without C4d deposition. Glomerular C4d deposition was associated with a high Oxford classification score, including M1, E1, S1, and T1/2 lesions (all P ≤ 0.006). Patients with C4d deposition had higher rates of use of renin-angiotensin system blockers and immunosuppressants. Glomerular C4d was found to be a risk factor for the composite kidney event (RR, 3.17; 95% CI, 2.29-4.40; P < 0.001; adjusted HR, 2.05; 95% CI, 1.53-2.76; P < 0.001) and end-stage kidney disease (RR, 4.37; 95% CI, 3.15-6.07; P < 0.001) without evidence of heterogeneity.

Limitations

The definition of positive C4d was not uniform and not all studies provided data about kidney outcomes.

Conclusions

Glomerular C4d deposition is associated with an adverse prognosis and may be a useful biomarker of disease prediction in IgAN.

SUBMITTER: Jiang Y 

PROVIDER: S-EPMC8664744 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8192385 | biostudies-literature
| S-EPMC5967419 | biostudies-literature
| S-EPMC8174712 | biostudies-literature
2022-02-01 | GSE166793 | GEO
| S-EPMC9727517 | biostudies-literature
| S-EPMC7470092 | biostudies-literature
| S-EPMC4237359 | biostudies-literature
| S-EPMC2441593 | biostudies-other
| S-EPMC5117702 | biostudies-literature
| S-EPMC6877440 | biostudies-literature